Charlestown, MANCT07177820Now EnrollingIRB Ready

Chemotherapy-induced Peripheral Neuropathy Clinical Trial in Charlestown, MA

Access cutting-edge chemotherapy-induced peripheral neuropathy treatment through this clinical trial at a research site in Charlestown. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Charlestown location

Preparing your pre-screening questions…

Expert Care in Charlestown

Access chemotherapy-induced peripheral neuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chemotherapy-induced peripheral neuropathy treatment provided free

Apply for This Charlestown Location

Check if you qualify for this chemotherapy-induced peripheral neuropathy clinical trial in Charlestown, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Charlestown

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Charlestown site if eligible
  4. 4Begin participation

About This Chemotherapy-induced Peripheral Neuropathy Study in Charlestown

Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

at least 18 years of age
have histologically confirmed stage I-III breast cancer,
have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.

Exclusion Criteria

concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
having metastatic or recurrent disease,
history of preexisting peripheral neuropathy prior to chemotherapy,
uncontrolled seizure disorder,
unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Charlestown?

Yes, this clinical trial (NCT07177820) has an active research site in Charlestown, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chemotherapy-induced Peripheral Neuropathy Treatment Options in Charlestown, MA

If you're searching for chemotherapy-induced peripheral neuropathy treatment options in Charlestown, MA, this clinical trial (NCT07177820) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Charlestown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chemotherapy-induced peripheral neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chemotherapy-induced peripheral neuropathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Charlestown, MA

See all pulmonary embolism clinical trials recruiting in Charlestown — not just this study.

Browse Pulmonary Embolism Trials in Charlestown

Ready to Join in Charlestown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Charlestown, MA